跳至主要内容
临床试验/CTRI/2025/04/084021
CTRI/2025/04/084021尚未招募不适用

Outcome of Osteoporotic Intertrochanteric Fractures treated with Cement Augmented Fenestrated Spiral Blade Cephalomeduallary Device In Elderly Population

AO Asia-Pacific Limited1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2025年4月15日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
30
试验地点
1
主要终点
The purpose of this

研究概览

简要总结

A study evaluating the significance of using Dual energy X-ray absorptiometry and osteoporosis profile for the

outcome evaluation of osteoporotic individuals having intramedullary fixation with cement augmentation and

uncemented has not been published in any of the literature. However In human cadaveric research, cement

augmentation of hip fracture implants has been investigated to enhance implant stability. To improve the

implant-bone interface, cement is injected into the osteoporotic bone of femoral head. The purpose of this

research was to assess the effectiveness of the new generation Trochanteric Femoral Nail Advanced

(TFNA)perforated helical blade cement augmentation or uncemented TFNA method to get the good outcome

in the osteoporotic individual and the cement distribution in the femoral head postoperatively.

研究设计

研究类型
Observational

入排标准

年龄范围
65.00 Year(s) 至 99.00 Year(s)(—)
性别
All

入选标准

  • inclusion: 1.AO/OTA-31-A1,A2 2.T-score of less than -2.5.

排除标准

  • 1.Pathological fracture 2.Multiple trauma 3.Delayed fracture more than 2 weeks.

结局指标

主要结局

The purpose of this

时间窗: 4 weeks, 12 weeks and 24 weeks

research was to assess the effectiveness of the new generation Trochanteric Femoral Nail Advanced

时间窗: 4 weeks, 12 weeks and 24 weeks

(TFNA)with perforated helical blades with cement augmentation and assessment of outcome in the osteoporotic hip fractures postoperatively.

时间窗: 4 weeks, 12 weeks and 24 weeks

次要结局

  • -(-)

研究者

发起方
AO Asia-Pacific Limited
申办方类型
Research institution
责任方
Principal Investigator
主要研究者

DR S P SIVAKUMAR

GANGA MEDICAL CENTRE HOSPITAL

研究点 (1)

Loading locations...

相似试验